Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|June 6, 1992
Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapyT Barbui, A Rambaldi, L Parenzan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 19, 1999
Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporineA Fassi, F Sangalli, F Colombi, et al.
Transplantation|July 1, 1991
Increased urinary excretion of endothelin-1 and its precursor, Big-endothelin-1, in rats chronically treated with cyclosporineA Benigni, N Perico, J R Ladny, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1994
Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporineP Ruggenenti, N Perico, C S Amuchastegui, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1994
Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is startedN Perico, S C Amuchastegui, V Colosio, et al.
The Journal of Experimental Medicine|November 1, 1994
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptidesG Remuzzi, M Noris, A Benigni, et al.
Transplantation Proceedings|December 1, 1991
FK 506 does not affect the glomerular filtration rate and renal plasma flow in the ratN Perico, C S Amuchastegui, C Zoja, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonismS C Amuchastegui, N Azzollini, M Mister, et al.
The American Journal of Physiology|March 10, 1999
ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathyA Remuzzi, N Perico, F Sangalli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantationD Cattaneo, S Merlini, S Zenoni, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|June 6, 1992
Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapyT Barbui, A Rambaldi, L Parenzan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 19, 1999
Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporineA Fassi, F Sangalli, F Colombi, et al.
Transplantation|July 1, 1991
Increased urinary excretion of endothelin-1 and its precursor, Big-endothelin-1, in rats chronically treated with cyclosporineA Benigni, N Perico, J R Ladny, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1994
Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporineP Ruggenenti, N Perico, C S Amuchastegui, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1994
Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is startedN Perico, S C Amuchastegui, V Colosio, et al.
The Journal of Experimental Medicine|November 1, 1994
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptidesG Remuzzi, M Noris, A Benigni, et al.
Transplantation Proceedings|December 1, 1991
FK 506 does not affect the glomerular filtration rate and renal plasma flow in the ratN Perico, C S Amuchastegui, C Zoja, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonismS C Amuchastegui, N Azzollini, M Mister, et al.
The American Journal of Physiology|March 10, 1999
ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathyA Remuzzi, N Perico, F Sangalli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantationD Cattaneo, S Merlini, S Zenoni, et al.
Pageof 15